BHVN

Quote

Short

News

Articles

Message Board

BHVN Price Target Alert: $23.00. Issued by Goldman Sachs

February 05, 2026 05:04:24 pm

Source: KlickAnalytics

2026-02-05 17:04:24 ET

from Goldman Sachs issued a price target of $23.00 for BHVN on 2026-02-05 21:18:00.

The adjusted price target was set to $23.00.

At the time of the announcement, BHVN was trading at $10.76.

The overall price target consensus is at $22.40 with high price of $42.00, low price of $11.00, and median price is at $22.00.

BHVN currently trades -75.80 ...
Full story available on KlickAnalytics.com

Biohaven Pharmaceutical Holding Company Ltd.

NASDAQ: BHVN

BHVN Trading

3.53% G/L:

$11.59 Last:

1,236,106 Volume:

$11 Open:

mwn-ir Ad 300

BHVN Latest News

February 05, 2026 05:04:24 pm

BHVN Price Target Alert: $23.00. Issued by Goldman Sachs

February 05, 2026 04:15:03 pm

Buy Recommendation Issued On BHVN By Goldman Sachs

January 21, 2026 05:15:12 am

Outperform Recommendation Issued On BHVN By RBC Capital

January 12, 2026 11:15:00 am

Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference

BHVN Stock Data

Market Cap $1,610,213,046

Float 113,271,989

Insiders Ownership 1.64%

Institutions 9

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Website https://www.biohavenpharma.com

Country US

City New Haven

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App